课题基金 / 基金详情

DESSTINI-DOSE ESCALATION SAFETY STUDY IN NORMAL INDIVIDUALS TAKING POLYMVA

DESSTINI-DOSE ESCALATION SAFETY STUDY IN NORMAL INDIVIDUALS TAKING POLYMVA
正常个体服用 Polymva 的 DESSTINI 剂量递增安全性研究
批准号:
7950828
负责人:
CANDICE J PERKINS
金额:
$0.68万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30

项目摘要

项目成果

CANDICE J PERKINS的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. We are studying the effects of Poly MVA, an experimental substance, in 15 healthy volunteers, to evaluate it's safety and tolerability. Poly MVA is made with Palladium, a heavy metal. This metal is bonded in such a way within the complex that no free metal is exposed, however we will monitor for potential metal toxicity as an added measure. We believe this supplement may be beneficial to patients who have suffered a stroke or who have cancer, because it may have an energy boost that transfers energy to cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AN OPEN-LABEL, PILOT STUDY OF SAFETY AND TOLERABILITY
TRIAL OF SIMVASTATIN TO SLOW THE PROGRESSION OF ALZEIMER'S DISEASE
POLY MVA UTILIZED AS NEUROPROTEIN IN CHRONIC HYPERTENSION
POLY MVA UTILIZED AS NEUROPROTEIN IN CHRONIC HYPERTENSION
海外基金